Tenderfy

Aseptically Prepared Systemic Anti-Cancer Therapy Medicines

Buyer
Mid South Essex NHS Foundation Trust
Published
2026-10-26
Deadline
Not provided
Sources
UK_FTS
Value
Not provided

Description

The description is in the source language.

This framework agreement is for the supply of a range of aseptically prepared, batch manufactured systemic anti-cancer therapy drugs in ready-to-administer presentations and agreed dose bands. The framework agreement will also cover the manufacturing and supply of patient specific systemic anti-cancer therapy drugs and medicines used in CIVAs.

Membership

Read notice previews free of charge. Official notice and document links, construction permits and personal MCP access require an active paid membership.

Read